Wall Street is positive on Aadi Bioscience Inc (AADI). On average, analysts give the stock a Strong Buy rating. The average price target is $50, which means analysts expect the stock to increase by 141.20% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating AADI a Strong Buy today. Find out what this means to you and get the rest of the rankings on AADI!
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Aadi Bioscience Inc Stock Today?
Aadi Bioscience Inc (AADI) stock is trading at $20.73 as of 2:57 PM on Wednesday, Jan 19, a loss of -$1.19, or -5.43% from the previous closing price of $21.92. The stock has traded between $20.24 and $21.90 so far today. Volume today is 237,299 compared to average volume of 200,389.
Click Here to get the full Stock Report for Aadi Bioscience Inc stock.